Cholecalciferol (vitamin D₃) improves myelination and recovery after nerve injury.

Low vitamin D levels are associated with higher opioid dose in palliative cancer patients--results from an observational study in Sweden. PLoS One (2015) 0.84

Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation. J Cell Biol (2015) 0.84

Dietary factors in the etiology of Parkinson's disease. Biomed Res Int (2015) 0.81

Vitamin D and Autism Spectrum Disorder: A Literature Review. Nutrients (2016) 0.78

Osteoporosis Self-Assessment Tool for Asians Can Predict Neurologic Prognosis in Patients with Isolated Moderate Traumatic Brain Injury. PLoS One (2015) 0.76

Vitamin D3 potentiates myelination and recovery after facial nerve injury. Eur Arch Otorhinolaryngol (2014) 0.76

Association of neovascular age-related macular degeneration with month and season of birth in Italy. Aging (Albany NY) (2016) 0.75

Experimental immunological demyelination enhances regeneration in autograft-repaired long peripheral nerve gaps. Sci Rep (2016) 0.75

Serum protein changes in a rat model of chronic pain show a correlation between animal and humans. Sci Rep (2017) 0.75

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99

Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr (1999) 6.64

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science (2001) 4.89

Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat (2005) 4.14

Functional evaluation of complete sciatic, peroneal, and posterior tibial nerve lesions in the rat. Plast Reconstr Surg (1989) 3.75

Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab (2004) 3.71

Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol (2005) 2.73

Role of Unc51.1 and its binding partners in CNS axon outgrowth. Genes Dev (2004) 2.34

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology (2010) 2.30

Maternal and postnatal vitamin D ingestion influences rat aortic structure, function and elastin content. Cardiovasc Res (2002) 2.24

Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron (1995) 2.19

Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int (1998) 2.07

Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab (2010) 2.02

Vitamin D3 and brain development. Neuroscience (2003) 2.01

Unc-51-like kinase 1/2-mediated endocytic processes regulate filopodia extension and branching of sensory axons. Proc Natl Acad Sci U S A (2007) 1.95

Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis (2005) 1.80

1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett (2003) 1.59

Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci (Lond) (1979) 1.49

Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res (2001) 1.46

Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology (2009) 1.45

Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr (2008) 1.40

LIM kinase and slingshot are critical for neurite extension. J Biol Chem (2007) 1.40

LIMK1 regulates Golgi dynamics, traffic of Golgi-derived vesicles, and process extension in primary cultured neurons. Mol Biol Cell (2004) 1.35

1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Brain Res Mol Brain Res (1994) 1.32

NFAT signaling in neural development and axon growth. Int J Dev Neurosci (2007) 1.30

Athletic performance and vitamin D. Med Sci Sports Exerc (2009) 1.29

Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology (2001) 1.27

Rat adipose tissue rapidly accumulates and slowly releases an orally-administered high vitamin D dose. Br J Nutr (1998) 1.22

25-hydroxycholecalciferol stimulation of muscle metabolism. J Clin Invest (1975) 1.22

Vitamin D(3) attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology (2000) 1.20

Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial. Ann Nutr Metab (2009) 1.19

Insulin-like growth factor 1 is essential for normal dendritic growth. J Neurosci Res (2003) 1.17

Developmental Vitamin D3 deficiency alters the adult rat brain. Brain Res Bull (2005) 1.15

Meteorin: a secreted protein that regulates glial cell differentiation and promotes axonal extension. EMBO J (2004) 1.14

1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. Neuroreport (1996) 1.13

1,25-dihydroxyvitamin D3 regulates the synthesis of gamma-glutamyl transpeptidase and glutathione levels in rat primary astrocytes. J Neurochem (1999) 1.13

1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum. J Neurosci Res (2009) 1.12

Brain target sites for 1,25-dihydroxyvitamin D3. Science (1982) 1.11

Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res (2005) 1.10

The tetraspanin protein, CD9, is expressed by progenitor cells committed to oligodendrogenesis and is linked to beta1 integrin, CD81, and Tspan-2. Glia (2002) 1.07

1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. Neuroreport (1994) 1.07

Role of muscle insulin-like growth factors in nerve sprouting: suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4. J Cell Biol (1994) 1.07

1,25 (OH)2 vitamin D3 sites of action in the brain. An autoradiographic study. Histochemistry (1987) 1.05

Four novel cases of periaxin-related neuropathy and review of the literature. Neurology (2010) 1.04

Expression of inducible nitric oxide synthase during rat brain inflammation: regulation by 1,25-dihydroxyvitamin D3. Glia (1998) 1.03

Effect of 1,25-dihydroxyvitamin D(3) on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4-phenylpyridine. J Neurosci Res (2000) 1.02

Evidence of functional vitamin D receptors in rat hippocampus. Neuroscience (2001) 1.02

Vitamin D Deficiency, hypocalcemia, and increased skeletal muscle degradation in rats. J Clin Invest (1983) 1.02

Changes in relaxation rate with diaphragmatic fatigue in humans. J Appl Physiol Respir Environ Exerc Physiol (1983) 1.02

Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro. Mol Cell Neurosci (2004) 1.00

Fatigue-induced changes in group IV muscle afferent activity: differences between high- and low-frequency electrically induced fatigues. Brain Res (1997) 0.95

Rat oligodendrocytes express the vitamin D(3) receptor and respond to 1,25-dihydroxyvitamin D(3). Glia (2000) 0.95

A novel rat tetraspan protein in cells of the oligodendrocyte lineage. J Neurochem (1999) 0.94

Effect of 1alpha,25-dihydroxyvitamin D3 in embryonic hippocampal cells. Hippocampus (2010) 0.94

Ca2+/calmodulin-dependent protein kinase IV-mediated LIM kinase activation is critical for calcium signal-induced neurite outgrowth. J Biol Chem (2009) 0.92

1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo. Brain Res (1998) 0.90

Chronic 1,25-dihydroxyvitamin D3-mediated induction of nerve growth factor mRNA and protein in L929 fibroblasts and in adult rat brain. Brain Res (1994) 0.88

1,25-Dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro. J Neurosci Res (1998) 0.87

Vitamin D2 potentiates axon regeneration. J Neurotrauma (2008) 0.87

Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the limbic system of the rat. Horm Metab Res (2001) 0.86

Discrimination in the metabolism of orally dosed ergocalciferol and cholecalciferol by the pig, rat and chick. Biochem J (1982) 0.86

IGF-I deficient mice show reduced peripheral nerve conduction velocities and decreased axonal diameters and respond to exogenous IGF-I treatment. J Neurobiol (1999) 0.84

Osteopontin is extensively expressed by macrophages following CNS demyelination but has a redundant role in remyelination. Neurobiol Dis (2008) 0.82

Modifications of afferent activities from Tibialis anterior muscle in rat by tendon vibrations, increase of interstitial potassium or lactate concentration and electrically-induced fatigue. J Peripher Nerv Syst (1998) 0.82

Changes in afferent activities from tibialis anterior muscle after nerve repair by self-anastomosis. Muscle Nerve (2001) 0.78

Self-prescribed high-dose vitamin D3: effects on biochemical parameters in two men. Ann Clin Biochem (2008) 0.77

An overview of cholecalciferol toxicosis. Vet Hum Toxicol (1999) 0.77

Respiratory and cardiovascular responses evoked by tibialis anterior muscle afferent fibers in rats. Exp Brain Res (2007) 0.76

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci U S A (2007) 4.04

Synthetic therapeutic peptides: science and market. Drug Discov Today (2009) 2.95

Gene expression profiling identifies molecular subtypes of inflammatory breast cancer. Cancer Res (2005) 2.26

Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene (2004) 2.09

Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers. Am J Pathol (2002) 1.89

Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res (2006) 1.66

Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy. Cancer Res (2004) 1.61

TranscriptomeBrowser: a powerful and flexible toolbox to explore productively the transcriptional landscape of the Gene Expression Omnibus database. PLoS One (2008) 1.60

High cytotoxic and specific migratory potencies of senescent CD8+ CD57+ cells in HIV-infected and uninfected individuals. J Immunol (2006) 1.55

A family of thermostable fungal cellulases created by structure-guided recombination. Proc Natl Acad Sci U S A (2009) 1.50

Herpes simplex virus thymidine kinase-mediated suicide gene therapy for hepatocellular carcinoma using HIV-1-derived lentiviral vectors. J Hepatol (2004) 1.49

Gene expression profiling defines molecular subtypes of classical Hodgkin's disease. Oncogene (2002) 1.44

Metzincin proteases and their inhibitors: foes or friends in nervous system physiology? J Neurosci (2010) 1.41

Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV. AIDS (2005) 1.40

CD8 T cell help for innate antitumor immunity. J Immunol (2007) 1.39

Gene expression profiles of poor-prognosis primary breast cancer correlate with survival. Hum Mol Genet (2002) 1.37

p8 improves pancreatic response to acute pancreatitis by enhancing the expression of the anti-inflammatory protein pancreatitis-associated protein I. J Biol Chem (2003) 1.35

Genetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modifications. BMC Cancer (2003) 1.34

Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genes. Cancer Res (2004) 1.30

Functional recovery after peripheral nerve injury and implantation of a collagen guide. Biomaterials (2008) 1.28

Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. Blood (2006) 1.28

A comparison of quality of care indicators in urban acute care hospitals and rural critical access hospitals in the United States. Int J Qual Health Care (2007) 1.27

Transplantation of olfactory ensheathing cells into spinal cord lesions restores breathing and climbing. J Neurosci (2003) 1.27

Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate. Eur J Neurosci (2003) 1.27

TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity. J Neuroimmunol (2002) 1.26

The human nose harbors a niche of olfactory ectomesenchymal stem cells displaying neurogenic and osteogenic properties. Stem Cells Dev (2010) 1.25

p8 is critical for tumour development induced by rasV12 mutated protein and E1A oncogene. EMBO Rep (2002) 1.23

STAT5-mediated signals sustain a TCR-initiated gene expression program toward differentiation of CD8 T cell effectors. J Immunol (2006) 1.22

Frequency-current relationships of rat hindlimb alpha-motoneurones. J Physiol (2006) 1.18

Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur J Neurosci (2002) 1.17

Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes. Glia (2010) 1.15

Gene-expression profiling discriminates between cerebral malaria (CM)-susceptible mice and CM-resistant mice. J Infect Dis (2005) 1.15

Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells. Mol Cell Neurosci (2008) 1.15

Does elimination of afferent input modify the changes in rat motoneurone properties that occur following chronic spinal cord transection? J Physiol (2007) 1.13

Tissue inhibitor of metalloproteinases-1 (TIMP-1) modulates neuronal death, axonal plasticity, and learning and memory. Eur J Neurosci (2005) 1.10

Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant mice. BMC Genomics (2007) 1.10

A candidate molecular signature associated with tamoxifen failure in primary breast cancer. Breast Cancer Res (2008) 1.10

Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease. Blood (2003) 1.09

Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profiling. Oncogene (2004) 1.07

Matrix metalloproteinase-2 (MMP-2) regulates astrocyte motility in connection with the actin cytoskeleton and integrins. Glia (2006) 1.04

TRAIL/Apo2L mediates the release of procoagulant endothelial microparticles induced by thrombin in vitro: a potential mechanism linking inflammation and coagulation. Circ Res (2009) 1.04

Engraftment of human nasal olfactory stem cells restores neuroplasticity in mice with hippocampal lesions. J Clin Invest (2011) 1.01

Neuromuscular rehabilitation by treadmill running or electrical stimulation after peripheral nerve injury and repair. J Appl Physiol (1985) (2003) 1.01

A new role for TIMP-1 in modulating neurite outgrowth and morphology of cortical neurons. PLoS One (2009) 1.01

A general survey of thymocyte differentiation by transcriptional analysis of knockout mouse models. J Immunol (2004) 1.01

Overexpression of c-Met and of the transducers PI3K, FAK and JAK in breast carcinomas correlates with shorter survival and neoangiogenesis. Int J Oncol (2007) 1.01

Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome. Int J Oncol (2004) 1.00

RAGE-TXNIP axis is required for S100B-promoted Schwann cell migration, fibronectin expression and cytokine secretion. J Cell Sci (2010) 1.00

Olfactory stem cells, a new cellular model for studying molecular mechanisms underlying familial dysautonomia. PLoS One (2010) 0.98

Extensive arterial aneurysm developing after surgical closure of long-standing post-traumatic popliteal arteriovenous fistula. J Vasc Surg (2004) 0.97

Evidence for early cognitive impairment related to frontal cortex in the 5XFAD mouse model of Alzheimer's disease. J Alzheimers Dis (2013) 0.96

FGFR1 and WT1 are markers of human prostate cancer progression. BMC Cancer (2006) 0.96

Gene expression profiling of 1p35-36 genes in neuroblastoma. Oncogene (2004) 0.96

CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients. Am J Clin Pathol (2003) 0.94

Prognosis of breast cancer and gene expression profiling using DNA arrays. Ann N Y Acad Sci (2002) 0.93

Platelets alter gene expression profile in human brain endothelial cells in an in vitro model of cerebral malaria. PLoS One (2011) 0.92

Developmental vitamin D deficiency alters learning in C57Bl/6J mice. Behav Brain Res (2010) 0.92

Long-term prognostic significance of neoangiogenesis in breast carcinomas: comparison of Tie-2/Tek, CD105, and CD31 immunocytochemical expression. Hum Pathol (2004) 0.91

Clarithromycin and prednisolone inhibit cytokine production in chronic rhinosinusitis. Laryngoscope (2002) 0.91

Severity of experimental autoimmune encephalomyelitis is unexpectedly reduced in mice born to vitamin D-deficient mothers. J Steroid Biochem Mol Biol (2010) 0.91

Trafficking and secretion of matrix metalloproteinase-2 in olfactory ensheathing glial cells: A role in cell migration? Glia (2011) 0.90

Genome-wide analysis of familial dysautonomia and kinetin target genes with patient olfactory ecto-mesenchymal stem cells. Hum Mutat (2012) 0.88

Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery. Med Res Rev (2012) 0.88

EMG versus oxygen uptake during cycling exercise in trained and untrained subjects. J Electromyogr Kinesiol (2004) 0.88

Vitamin D2 potentiates axon regeneration. J Neurotrauma (2008) 0.87

TranscriptomeBrowser 3.0: introducing a new compendium of molecular interactions and a new visualization tool for the study of gene regulatory networks. BMC Bioinformatics (2012) 0.87

TWEAK is expressed at the cell surface of monocytes during multiple sclerosis. J Leukoc Biol (2008) 0.87

LRP-1--CD44, a new cell surface complex regulating tumor cell adhesion. Mol Cell Biol (2012) 0.87

Resuscitation of hypoxic piglets with 100% O2 increases pulmonary metalloproteinases and IL-8. Pediatr Res (2005) 0.86

Mapping of domains on HIV envelope protein mediating association with calnexin and protein-disulfide isomerase. J Biol Chem (2010) 0.85

TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier. J Neuroinflammation (2013) 0.85

Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study. BMC Neurosci (2005) 0.85

Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease. Mol Neurodegener (2014) 0.85

DNA arrays in clinical oncology: promises and challenges. Lab Invest (2003) 0.85

Mouse lumbar and cervical spinal cord blood flow measurements by arterial spin labeling: sensitivity optimization and first application. Magn Reson Med (2009) 0.84

Olfactory neural cells: an untapped diagnostic and therapeutic resource. The 2000 Ogura Lecture. Laryngoscope (2002) 0.84

An evaluation of the role of gene expression in the prediction and diagnosis of ventilator-associated pneumonia. Anesthesiology (2011) 0.84

Isolated capitate shortening osteotomy for the early stage of Kienböck disease with neutral ulnar variance. Plast Reconstr Surg (2009) 0.84

Effects of neonatal capsaicin deafferentation on neuromuscular adjustments, performance, and afferent activities from adult tibialis anterior muscle during exercise. J Neurosci Res (2004) 0.84

Selective training-induced thigh muscles hypertrophy in professional road cyclists. Eur J Appl Physiol (2006) 0.83

Expression profile of peripheral tissue antigen genes in medullary thymic epithelial cells (mTECs) is dependent on mRNA levels of autoimmune regulator (Aire). Immunobiology (2012) 0.83

Dynamic distribution of Spatial during mouse spermatogenesis and its interaction with the kinesin KIF17b. Exp Cell Res (2006) 0.83

Gene expression profiles characterize inflammation stages in the acute lung injury in mice. PLoS One (2010) 0.83

Gene profiling approach to establish the molecular bases for partial versus full activation of naïve CD8 T lymphocytes. Ann N Y Acad Sci (2002) 0.83

The potential role of metalloproteinases in neurogenesis in the gerbil hippocampus following global forebrain ischemia. PLoS One (2011) 0.82

Cognitive Workload and Psychophysiological Parameters During Multitask Activity in Helicopter Pilots. Aerosp Med Hum Perform (2015) 0.82

[The immunohistochemical expression of CD105 is a marker for high metastatic risk and worse prognosis in breast cancers]. Bull Acad Natl Med (2003) 0.82

Role of matrix metalloproteinases in migration and neurotrophic properties of nasal olfactory stem and ensheathing cells. Cell Transplant (2012) 0.81

Resuscitation of hypoxic newborn piglets with supplementary oxygen induces dose-dependent increase in matrix metalloproteinase-activity and down-regulates vital genes. Pediatr Res (2010) 0.81

Structurally flexible triethanolamine core PAMAM dendrimers are effective nanovectors for DNA transfection in vitro and in vivo to the mouse thymus. Bioconjug Chem (2011) 0.81

Matched adaptations of electrophysiological, physiological, and histological properties of skeletal muscles in response to chronic hypoxia. Pflugers Arch (2004) 0.81

Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease. Hippocampus (2014) 0.80